PL2433629T3 - Zastosowanie kwasów bosweliowych w profilaktyce i/lub leczeniu uszkodzeń i/lub zapalenia wysepek Langerhansa - Google Patents

Zastosowanie kwasów bosweliowych w profilaktyce i/lub leczeniu uszkodzeń i/lub zapalenia wysepek Langerhansa

Info

Publication number
PL2433629T3
PL2433629T3 PL10178222T PL10178222T PL2433629T3 PL 2433629 T3 PL2433629 T3 PL 2433629T3 PL 10178222 T PL10178222 T PL 10178222T PL 10178222 T PL10178222 T PL 10178222T PL 2433629 T3 PL2433629 T3 PL 2433629T3
Authority
PL
Poland
Prior art keywords
islets
langerhans
prophylaxis
damages
inflammation
Prior art date
Application number
PL10178222T
Other languages
English (en)
Inventor
Hermann P.T. Ammon
Original Assignee
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. filed Critical Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Publication of PL2433629T3 publication Critical patent/PL2433629T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL10178222T 2010-09-22 2010-09-22 Zastosowanie kwasów bosweliowych w profilaktyce i/lub leczeniu uszkodzeń i/lub zapalenia wysepek Langerhansa PL2433629T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10178222.5A EP2433629B1 (en) 2010-09-22 2010-09-22 Use of boswellic acids for the prophylaxis and/or treatment of damages and/or inflammation of the islets of Langerhans

Publications (1)

Publication Number Publication Date
PL2433629T3 true PL2433629T3 (pl) 2018-04-30

Family

ID=43061397

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10178222T PL2433629T3 (pl) 2010-09-22 2010-09-22 Zastosowanie kwasów bosweliowych w profilaktyce i/lub leczeniu uszkodzeń i/lub zapalenia wysepek Langerhansa

Country Status (7)

Country Link
US (1) US8975228B2 (pl)
EP (2) EP2433629B1 (pl)
JP (1) JP5952821B2 (pl)
ES (1) ES2655885T3 (pl)
NO (1) NO2433629T3 (pl)
PL (1) PL2433629T3 (pl)
WO (1) WO2012038251A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE537397C2 (sv) 2013-06-28 2015-04-21 Alelion Batteries Ab Batterianordning för eldrivna industrifordon
US9975917B1 (en) 2017-09-20 2018-05-22 King Saud University Pentacyclic triterpenoidal derivatives
GB2581318A (en) * 2018-11-26 2020-08-19 Adrian John Jackson Adam Novel compositions
CN110169971A (zh) * 2019-04-18 2019-08-27 天津中医药大学 一种包含3乙酰-α、β乳香酸的药物及其在预防、治疗胰腺炎中的应用
CN115414366B (zh) * 2022-08-23 2023-11-03 武汉科前生物股份有限公司 11-酮基-beta-乳香酸在制备治疗猫杯状病毒病的药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1173162A1 (en) * 1999-04-30 2002-01-23 Sabinsa Corporation Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
US20020102231A1 (en) * 1999-05-07 2002-08-01 Icos Corporation Therapeutic uses of PAF-AH products in diabetes
CA2408818A1 (en) 2000-05-11 2001-11-15 Oklahoma Medical Research Foundation Prevention of insulin-dependent diabetes, complications thereof, or allograft rejection by inhibition of cyclooxygenase-2 activity with ns398 or pdtc
DE10035591A1 (de) * 2000-07-21 2002-01-31 Hasan Safayhi Verfahren zur Isolierung von tetra-und pentacyclischen Triterpensäuren
US20060148732A1 (en) * 2000-11-17 2006-07-06 Gutterman Jordan U Inhibition of NF-kappaB by triterpene compositions
WO2003077860A2 (en) * 2002-03-13 2003-09-25 Biophysica, Inc. BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES
US20050282772A1 (en) * 2004-06-21 2005-12-22 Gokaraju Ganga R New dietary supplement composition for obesity and inflammation
KR20080041703A (ko) * 2005-08-23 2008-05-13 액세스 비지니스 그룹 인터내셔날 엘엘씨 사이토킨 조절인자 및 관련된 이용 방법
US20070048246A1 (en) * 2005-09-01 2007-03-01 Biophysica Research, Inc. Novel skin care compositions
JP2007326839A (ja) * 2006-06-06 2007-12-20 Waccord:Kk 糖尿病、歯周病および関節炎の改善を目的とする健康食品
US20100099756A1 (en) * 2006-11-29 2010-04-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Uses of incensole, incensole acetate and derivatives thereof
WO2010029578A2 (en) * 2008-09-15 2010-03-18 Ganga Raju Gokaraju Synergistic anti-inflammatory compositions comprising boswellia serrata extracts

Also Published As

Publication number Publication date
JP2013537894A (ja) 2013-10-07
WO2012038251A1 (en) 2012-03-29
EP3338773A1 (en) 2018-06-27
NO2433629T3 (pl) 2018-04-07
EP2433629B1 (en) 2017-11-08
US8975228B2 (en) 2015-03-10
EP2433629A1 (en) 2012-03-28
US20120070497A1 (en) 2012-03-22
JP5952821B2 (ja) 2016-07-13
ES2655885T3 (es) 2018-02-22

Similar Documents

Publication Publication Date Title
IL227193B (en) Plant extracts for the treatment and prevention of infections
PL2668182T3 (pl) Inhibitowanie IL17 i IFN-gamma do leczenia zapalenia autoimmunologicznego
PT2668183T (pt) Inibição de il-7 e de ifn gama para o tratamento de inflamação autoimune
ZA201302979B (en) Dianosis and treatment relating to th2 inhibition
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
HUE039219T2 (hu) Gyógyászati készítmény rák kezelésére és/vagy megelõzésére
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
SI3378862T1 (sl) Dihidropirimidinoizokuinolini in farmacevtski sestavki le-teh za zdravljenje multiple skleroze
GB201302652D0 (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
EP2574172A4 (en) MATERIALS AND METHOD FOR TREATING INFLAMMATION
GB2503066B (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
PL2830654T3 (pl) Sposoby i kompozycje do leczenia zapalenia
SG10201502583VA (en) Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
ZA201200608B (en) L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin
SG11201504542PA (en) Probiotic strains for the treatment and/or prevention of diarrhœa
PL2575971T3 (pl) Połączone wyciągi roślinne do zastosowania w leczeniu zakażeń drobnoustrojami
ZA201604225B (en) Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus
PL2731616T3 (pl) Sposób profilaktyki i leczenia sepsy
GB201302656D0 (en) A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
IL238126A0 (en) Compositions for the treatment and prevention of obesity
PL2854748T3 (pl) Kompozycja farmaceutyczna do leczenia zapalenia skóry i powiązanych syndromów
ZA201306087B (en) Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
AU2011902394A0 (en) Prevention and treatment of acute inflammatory conditions
AU2013904048A0 (en) Compositions and methods for the prevention and/or treatment of neurogenic inflammation and/or infla
IL221238A0 (en) Pharmaceutical compositions and methods for the treatment and prevention of cancer